Cahill Represents Underwriters in Common Stock Offering by VIVUS
Date: 03/06/12
Cahill represented J.P. Morgan as sole book-running manager and BofA Merrill Lynch, JMP Securities, Needham & Company, and Rodman & Renshaw as co-managers in connection with the public offering of 9,000,000 shares of common stock of biopharmaceutical company VIVUS, Inc. (NASDAQ: VVUS) resulting in gross proceeds of $202.5 million. The net proceeds will be used primarily to commercialize the company’s Qnexa product in the U.S. (if approved) for the treatment of obesity, to pursue marketing approvals outside the U.S. and for general corporate purposes.